Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
Abstract A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively...
Main Authors: | Akiko Hashimoto, Yasuhiro Tanaka, Takayuki Ishikawa, Isaku Shinzato |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4417 |
Similar Items
-
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
by: Akiko Hashimoto, et al.
Published: (2021-07-01) -
On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01) -
Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: A case Series
by: Gaurav Shah, et al.
Published: (2020-09-01) -
The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
by: Hong-Hu Zhu
Published: (2020-11-01) -
Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy
by: S. Venkatesan, et al.
Published: (2015-01-01)